Search results for the GEO ID: GSE17480
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM435978
GPL570
CD34+ cells without fenretinide treatment from CML32 CD34+ cells from the patient (CML32) disease status: CML chronic phase (CP) cell source: leukapheresis products (LP) cell type: CD34+ mononuclear cells Untreated CD34+ cells isolated from the patient CML32, harvested after 48h in culture
GSM435979
GPL570
CD34+ cells with fenretinide treatment from CML32 CD34+ cells from the patient (CML32) disease status: CML chronic phase (CP) cell source: leukapheresis products (LP) cell type: CD34+ mononuclear cells Fenretinide-treated CD34+ cells isolated from the patient CML32, harvested after 48h in culture
GSM435980
GPL570
CD34+ cells without fenretinide treatment from CML33 CD34+ cells from the patient (CML33) disease status: CML chronic phase (CP) cell source: leukapheresis products (LP) cell type: CD34+ mononuclear cells Untreated CD34+ cells isolated from the patient CML33, harvested after 48h in culture
GSM435981
GPL570
CD34+ cells with fenretinide treatment from CML33 CD34+ cells from the patient (CML33) disease status: CML chronic phase (CP) cell source: leukapheresis products (LP) cell type: CD34+ mononuclear cells Fenretinide-treated CD34+ cells isolated from the patient CML33, harvested after 48h in culture
GSM435982
GPL570
CD34+ cells without fenretinide treatment from CML34 CD34+ cells from the patient (CML34) disease status: CML chronic phase (CP) cell source: bone marrow (BM) cell type: CD34+ mononuclear cells Untreated CD34+ cells isolated from the patient CML34, harvested after 48h in culture
GSM435983
GPL570
CD34+ cells with fenretinide treatment from CML34 CD34+ cells from the patient (CML34) disease status: CML chronic phase (CP) cell source: bone marrow (BM) cell type: CD34+ mononuclear cells Fenretinide-treated CD34+ cells isolated from the patient CML34, harvested after 48h in culture
GSM435984
GPL570
CD34+ cells without fenretinide treatment from CML35 CD34+ cells from the patient (CML35) disease status: CML chronic phase (CP) cell source: leukapheresis products (LP) cell type: CD34+ mononuclear cells Untreated CD34+ cells isolated from the patient CML35, harvested after 48h in culture
GSM435985
GPL570
CD34+ cells with fenretinide treatment from CML35 CD34+ cells from the patient (CML35) disease status: CML chronic phase (CP) cell source: leukapheresis products (LP) cell type: CD34+ mononuclear cells Fenretinide-treated CD34+ cells isolated from the patient CML35, harvested after 48h in culture
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes